Invasive fungal infections in pediatric hematopoietic stem cell transplant patients

Infectious Diseases

Volumn 47, Issue 4, 2015, Pages 218-224

  Simms Waldrip, Tiffany ^a   Rosen, Galit ^b   Nielsen Saines, Karin ^c   Ikeda, Alan ^a   Brown, Berkley ^a   Moore, Theodore ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aspergillus; Candida; Fungal infections; HSCT; Pediatric; Stem cell transplant

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; BLOOD; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CEREBROSPINAL FLUID; CHILD; COHORT ANALYSIS; DEATH; ENGRAFTMENT; FUNGAL STRAIN; GASTROINTESTINAL TRACT; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; IMMUNOCOMPROMIZED PATIENT; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; MOULD; NEUTROPENIA; NEWBORN; PEDIATRICS; PICHIA KUDRIAVZEVII; PROPHYLAXIS; RESPIRATORY SYSTEM; SURVIVAL; SYSTEMIC MYCOSIS; URINE; ADVERSE EFFECTS; INCIDENCE; MICROBIOLOGY; MYCOSES; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MYCOSES; RETROSPECTIVE STUDIES;

EID: 84983122159     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365548.2014.985709     Document Type: Article

References (34)

1. Bhatti Z, Shaukat A, Almyroudis N G, Segal B H.Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients Mycopathologia 2006; 162: 1-15.
2. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski, et al Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation Bone Marrow Transplant 2007; 40: 1055-62.
3. Oshima K, Kanda Y, Asano-Mori Y, Nishimoto N, Arai S, Nagai S, et al Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients J Antimicrob Chemother 2007; 60: 350-5.
4. Pagano L, Caira M, Nosari A, Van Lint M T, Candoni A, Offidani M, et al Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne Clin Infect Dis 2007; 45: 1161-70.
5. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, et al Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stemcell transplantation: systematic review and meta-Analysis J Clin Oncol 2007; 25: 5471-89.
6. Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, et al Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole Bone Marrow Transplant 2007; 40: 451-6.
7. Winston DJ, Maziarz RT, Chandrasekar PH, Lazarua HM, Goldman M, Blumer JL, et al Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients A multicenter, randomized trial Ann Intern Med 2003; 138: 705-13.
8. De La Rosa GR, Champlin RE, Kontoyiannis DP Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients Transpl Infect Dis 2002; 4: 3-9.
9. Hovi L, Saarinen-Pihkala U M, Vettenranta K, Saxen H.Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years Bone Marrow Transplant 2000; 26: 999-1004.
10. Marr KA, Carter RA, Boeckh M, Martin P, Corey L.Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 2002; 100: 4358-66.
11. Wingard JR, Hsu J, Hiemenz JW Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology Infect Dis Clin North Am 2010; 24: 257-72.
12. G öz da o l u S, Ertem M, Bü yü kke ç eci Z, Yavuzdemir S, Bengisun S, Ozenci H, et al Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy Med Pediatr Oncol 1999; 32: 344-8.
13. Maertens J, Vrebos M, Boogaerts M.Assessing risk factors for systemic fungal infections Eur J Cancer Care (Engl) 2001; 10: 56-62.
14. Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupl J, Kunova A, et al Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome J Antimicrob Chemother 1998; 41: 373-80.
15. Dvorak C C, Steinbach W J, Brown J M, Agarwal R.Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation Bone Marrow Transplant 2005; 36: 621-9.
16. Chou L S, Lewis R E, Ippoliti C, Champlin R E, Kontoyiannis DP Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients Pharmacotherapy 2007; 27: 1644-50.
17. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective Biol Blood Marrow Transplant 2009; 15: 1143-238.
18. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer Am J Med 2002; 112: 380-5.
19. Rosen G P, Nielsen K, Glenn S, Abelson J, Deville J, Moore TB Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution J Pediatr Hematol Oncol 2005; 27: 135-40.
20. Abelson J A, Moore T, Bruckner D, Deville J, Nielsen K.Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution Pediatrics 2005; 116: 61-7.
21. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K.Trends in the postmortem epidemiology of invasive fungal infections at a university hospital J Infect 1996; 33: 23-32.
22. Marr K A, Carter R A, Crippa F, Wald A, Corey L.Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis 2002; 34: 909-17.
23. Wald A, Leisenring W, v an Burik JA, Bowden RA Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation J Infect Dis 1997; 175: 1459-66.
24. Kontoyiannis DP, Reddy BT, Torres HA, Luna M, Lewis RE, Tarrand J, et al Pulmonary candidiasis in patients with cancer: an autopsy study Clin Infect Dis 2002; 34: 400-3.
25. Kami M, Machida U, Okuzumi K, Matsumura T, Mori Si S, Hori A, et al Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy Br J Haematol 2002; 117: 40-6.
26. Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation British Society for Medical Mycology Eur J Clin Microbiol Infect Dis 1997; 16: 424-36.
27. Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M.Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT AJR Am J Roentgenol 1997; 169: 1347-53.
28. Kami M, Kishi Y, Hamaki T, Kawabata M, Kashima T, Masumoto T, et al The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis An autopsy-based retrospective study of 48 patients Mycoses 2002; 45: 287-94.
29. Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, et al Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia J Clin Oncol 2001; 19: 253-9.
30. Thornton CR Detection of invasive aspergillosis A dv Appl Microbiol 2010; 70: 187-216.
31. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-A prospective, randomized, double-blind study J Infect Dis 1995; 171: 1545-52.
32. Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers ME, et al Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Blood 2000; 96: 2055-61.
33. Wingard JR, Carter S L, Walsh TJ, Kurtzberg J, Small TN, Baden LR, et al Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation Blood 2010; 116: 5111-18.
34. Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease N Engl J Med 2007; 356: 335-47.